Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine.
Fish are an important model for the pharmacological and toxicological characterization of human pharmaceuticals in drug discovery, drug safety assessment and environmental toxicology. However, do fish respond to pharmaceuticals as humans do? To address this question, we provide a novel quantitative...
Main Authors: | Luigi Margiotta-Casaluci, Stewart F Owen, Rob I Cumming, Anna de Polo, Matthew J Winter, Grace H Panter, Mariann Rand-Weaver, John P Sumpter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4206295?pdf=render |
Similar Items
-
Environmental Occurrence and Predicted Pharmacological Risk to Freshwater Fish of over 200 Neuroactive Pharmaceuticals in Widespread Use
by: John P. Sumpter, et al.
Published: (2022-05-01) -
A new role for carbonic anhydrase 2 in the response of fish to copper and osmotic stress: implications for multi-stressor studies.
by: Anna de Polo, et al.
Published: (2014-01-01) -
Fluoxetine improves minor depressive disorders.
by: Cowen, P
Published: (2005) -
Fluoxetine results in misleading conclusions on fish behavior
by: Malgorzata Grzesiuk, et al.
Published: (2021-07-01) -
Fluoxetine versus other types of pharmacotherapy for depression.
by: Cipriani, A, et al.
Published: (2005)